TABLE IVB.
5-Year Disease-Specific Survival Over Time
| Total | 1988–1992 | 1993–1997 | 1998–2001 | P-value | |
|---|---|---|---|---|---|
| Overall survival | 94.8% (±0.9) | 92.1% (±1.8) | 94.6% (±1.4) | 98.5% (±0.9) | P =0.04 |
| Surgery type | P =0.26 | ||||
| FPSa | 97.9% (±0.9) | 96.6% (±1.9) | 97.6% (±1.4) | 100.0% (±0.0) | P =0.28 |
| Standard surgeryb | 95.6% (±1.6) | 93.3% (±3.2) | 95.4% (±2.3) | 100.0% (±0.0) | P =0.29 |
| Lymphadenectomy | P =0.013 | ||||
| Yes | 96.8% (±1.1) | 97.4% (±1.8) | 94.5% (±2.2) | 100.0% (±0.0) | P =0.12 |
| No | 92.3% (±1.4) | 87.8% (±2.9) | 94.7% (±1.8) | 96.6% (±1.9) | P =0.04 |
| Histology | P <0.001 | ||||
| Dysgerminoma | 99.1% (±0.6) | 100.0% (±0.0) | 97.6% (±1.6) | 100.0% (±0.0) | P =0.19, P =0.33 |
| FPSa | 98.9% (±1.1) | 100.0% (±0.0) | 96.3% (±3.6) | 100.0% (±0.0) | P =0.32 |
| Standard surgeryb | 100.0% (±0.0) | 100.0% (±0.0) | 100.0% (±0.0) | 100.0% (±0.0) | — |
| Immature teratoma | 94.3% (±1.2) | 90.3% (±2.7) | 95.0% (±1.7) | 98.8% (±1.2) | P =0.02, P =0.24 |
| FPSa | 98.3% (±1.0) | 97.9% (±2.1) | 97.5% (±1.7) | 100.0% (±0.0) | P =0.56 |
| Standard surgeryb | 95.7% (±2.1) | 89.6% (±5.7) | 97.5% (±2.5) | 100.0% (±0.0) | P =0.13 |
| Yolk sac tumor | 84.6% (±4.1) | 77.8% (±8.0) | 86.1% (±5.8) | 94.5% (±3.8) | P =0.43 |
| FPSa | 92.9% (±4.9) | 81.8% (±11.6) | 100.0% (±0.0) | 100.0% (±0.0) | P =0.19 |
| Standard surgeryb | 84.2% (±7.4) | 80.0% (±17.9) | 81.3% (±9.8) | 100.0% (±0.0) | P =0.61, P =0.45 |
a
Fertility-preserving surgery.
b
Hysterectomy and debulking.